CE Snips - Neuroinflammation in Alzheimer’s Disease: Implications for Early Detection and Treatment
This activity is supported by an educational grant from Novo Nordisk, Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Novo Nordisk, Inc.
Activity Description
Alzheimer’s disease (AD) is an irreversible, age-related neurodegenerative disorder characterized by a gradual decline in understanding, memory, and ability to perform activities of daily living. With the recent approval of novel AD treatments and the evolving therapeutic landscape, it is imperative for clinicians to stay informed on the current issues surrounding AD. This CE program "Neuroinflammation in Alzheimer’s Disease: Implications for Early Detection and Treatment" aims to address this need by focusing on the role of neuroinflammation in AD, the importance of timely screening and diagnosis, and the latest therapeutic options and emerging approaches. Through a series of 3 CE Snips text-based modules, participants will first gain a comprehensive understanding of the pathophysiological mechanisms underlying AD, including how neuroinflammation contributes to disease progression. A module will then highlight the significance of early detection and review the tools that facilitate timely diagnosis, ultimately aiding in better patient outcomes. Finally, a module will examine clinical evidence for current and emerging treatments for the management of patients with AD.
Target Audience
The intended audience for this activity includes neurologists, primary care physicians, geriatric specialists, psychiatrists, neurology nurses, nurse practitioners, physician associates, and other healthcare professionals involved in the management of patients with AD.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Evaluate the pathophysiological mechanisms underlying AD including the role of neuroinflammation in the progression of the disease.
- Examine the importance of early detection of AD and tools that aid in the timely diagnosis.
- Review the clinical evidence for current and emerging treatments for AD.
Faculty
Sharon Cohen, MD, FRCPC
Medical Director and Site Principal Investigator
Toronto Memory Program
Toronto, Ontario Canada
Cynthia A. Lemere, BA, MS, PhD
Professor of Neurology
Brigham and Women's Hospital
Harvard Medical School
Boston, MA
Marwan Noel Sabbagh, MD, FAAN, FANA
Moreno Family Chair for Alzheimer's Research
Vice Chairman for Research and Professor
Department of Neurology
Barrow Neurological Institute
Phoenix, AZ
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, BS, PA-C
Medical Writers
Amy E. Cyr, MD
Kaci Durbin, MD, MBA
Valerie Zimmerman, PhD
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participants who opt-in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.
Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 6/29/2025. PAs should only claim credit commensurate with the extent of their participation.
This enduring material is approved for 1 year from the date of original release, June 30, 2024, to June 29, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 of the 5 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate or AAPA Category 1 CME certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Faculty report the following relevant financial relationship(s)
Sharon Cohen, MD, FRCPC
Independent Research Contractor (paid to institution): AbbVie, AgeneBio, Alector, Alnylam, Alzheon, Anavex, Biogen, Cassava, Eisai, GAP, Janssen, Lilly, Novo Nordisk, RetiSpec, Roche, UCB
Cynthia A. Lemere, BA, MS, PhD
Consultant: ADvantage, Alnylam, Apellis, Biogen, Cyclo, Novo Nordisk
Independent Research Contractor: AC Immune, Merck, Novo Nordisk
Marwan Noel Sabbagh, MD, FAAN, FANA
Advisor: AbbVie, Anavax, Cognito, Eisai, GSK, KeiferRx, Lilly, NeuroTherapia, Novo Nordisk, Prothena, Roche, Signant, Synaptogenix
Consultant: AbbVie, Anavax, Cognito, Eisai, GSK, KeiferRx, Lilly, NeuroTherapia, Novo Nordisk, Prothena, Roche, Signant, Synaptogenix
Stock Options: Alzheon, uMethod Health
Individual Stocks (publicly traded): Athira
*Individual Stocks (privately held): Lighthouse Pharmaceuticals, NeuroReserve, NeuroTau, Optimal Cognitive Health Company, SeqBioMarque, Transdermix, Versanum
Board of Directors: EIP Pharma/CervoMed
*Does not discuss the business lines or products of the companies.
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.
Medical Writers report the following relevant financial relationship(s)
Amy E. Cyr, MD
No relevant financial relationships to disclose.
Kaci Durbin, MD, MBA
No relevant financial relationships to disclose.
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
The modules within this activity were composed by Medical Writers Amy E. Cyr, MD, Kaci Durbin, MD, MBA, and Valerie Zimmerman, PhD, based on direction provided by Drs. Cohen, Lemere, and Sabbagh. Each module has been approved by the respective faculty individually.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com